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Abstract - A complete instrument for the measurement of 
erythrocyte (red blood cell) flow in microchannels is presented. 
The instrument measures circa 1500 cells on a cell-by-cell basis 
in an array of microchannels. Microchannel dimensions and 
operating pressures are physiologically-analogous. Resulting 
hi-variate data, obtained by real-time image processing, 
describes cell flow with a unique volume-velocity space 
representation which provides detailed insights into both cell 
flow resistance (independent of  cell volume) and the presence 
of pathological sub-populations. 
We commence by discussing the instrument’s design, with 
particular attention to the microflnidics. We proceed to report 
analyses o f  the instrument’s reproducibility, the 
characterisation of normal blood, and our ability to detect 
artificial sub-populations of cells with rigid membranes 
produced by chemically modifying a fraction o f  the analyte. 
Having validated the performance of the instrument, we then 
present a clinical result from a transfused thalassaemic 
displaying highly irregular microrheological metria. 
I. INTRODUCTION 
A. Microvascular Haemodynumics 
Blood is a complex two phase fluid consisting of solid 
bodies, the blood cells, in suspension within an aqueous 
liquid phase, the plasma. To perform its primary 
physiological roles of nutrient transport, waste transport and 
deployment of white cells, the blood must flow through the 
vast, diverse network of vessels which constitute the 
circulatory system. At one extreme, human blood vessels 
are several centimetres in diameter and blood flows through 
this region as a continuous body obeying bulk fluid laws. 
This situation ceases to apply within the capillary beds, 
where the exchange of nutrient gases is performed. Here 
vessel diameters are just a few microns: smaller than the 
blood cells themselves. Within this region, cells must 
deform to squeeze through the vessels in single-file to 
perform their critical roles. 
By far the most numerous of blood cells is the 
erythrocyte. These consist of an under-filled, viscoelastic 
membrane encasing a viscous liquid interior. At rest these 
highly specialised cells take the form of a biconcave disk, 
typically of 8 pm diameter and 2 pm thickness. 
The ability of the erythrocyte to deform is dependent 
on the intrinsic mechanical properties of its constituent 
parts and extrinsic factors characterised by its volume and 
specific morphology. Within the vascular network, blood 
cells are subjected to static, time invariant deformation but 
they must also deform dynamically: in response to time- 
varying deformational forces. This is a critical mechanism 
by which erythrocytes can transit the tortuous environment 
of the capillary beds. 
Microhaemorheology is the study of the mechanisms of 
cellular deformation and blood flow at the single cell level. 
Much experimental work has concentrated on measuring 
the intrinsic mechanical properties of erythrocytes [ l ]  and 
the ability of the blood cells to pass through (non 
microengineered) filter-type structures [2].  
Measurements of cellular mechanical properties of 
several pathological states have indicated impaired cellular 
deformation characteristics [l]. Ultimately however, a cell’s 
ability to transit a microvessel environment is perhaps a 
more telling indication of the physiological implications 
these cytomechanical changes may have. Unfortunately 
little work is reported on in-vitro measurements of blood 
cells flowing under controlled, physiologically-analogous 
conditions. Here we present a microhaemeorheological 
instrument designed to approach these issues. 
B. Cyto-Manipulation on Chip 
Whilst the potential of whole cell handling with 
microfluid systems is recognised, a limited volume of work 
has been reported thus far. This work has centred upon 
three areas: cell mechanics; DNA extraction; and cell 
sorting and handling. 
Cell mechanical studies probably represented the 
earliest of these areas to be investigated. Original work 
employed KOH-etched silicon as a discrete filter 
component without cell-by-cell data extraction [3]. 
Subsequently we integrated silicon flow structures into an 
instrument employing image processing to provide cell-by- 
cell data extraction [4], IS], [6] .  Two groups 171 and [SI 
reported the studies of flow in microfabricated vessels of 
larger than microvascular dimensions. In [9] a device 
employing repeated banks of microvascular-dimensioned 
channels was employed to investigate an hypothesis that 
erythrocyte membrane deformability changed in response to 
repeated deformation. 
The desirability of being able to conduct DNA analyses 
based upon low trauma cell sampling via finger-prick 
sampling or buccal swabs, with their concomitant low 
sample volumes, has lead several groups to investigate 
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microfluid-based white cell separation and subsequent on- 
chip lysis for DNA extraction. One approach has been to 
employ filter structures to pass erythrocytes whilst trapping 
white cells [lo]. 
Amongst examples of cell sorting and handling, [11] 
reports the separation of rare foetal blood cells that have 
migrated into the maternal circulation thereby promising 
non-invasive foetal screening. Reference [ 121 reports the 
use of microfluidics for embryo manipulation in, for 
instance, IVF and cloning. 
We have continued to develop our blood cell analysis 
system to the point where it can reliably assess samples and 
function as a haemorheological tool. In the following 
section we discuss the evolution of the instrument to this 
point. 
11. THE INSTRUMENT 
The instrument, shown in Fig. 1 can be delineated into 
four distinct topics: microfluidics, macrofluidics, real-time 
image processing, and data post-processing. 
A. Microfluidic Considerations 
Microflnidics, particularly in the guise of ‘lab-on-a- 
chip’ is highly topical. Typical devices (for instance 
electrophoresis chips) are often characterised by relatively 
large feature sizes, the use of glass and plastics as substrate 
materials, and the use of electrokinetics as a fluid transport 
mechanism. Work reported to date is predominately liquid 
phase with more recent developments focusing upon a 
suspended phase in the form of bead supports for solid 
phase chemistry 1131. 
Our devices differ somewhat. They require fine feature 
sizes to provide the precise control of the cell’s 
environment. They employ hydrostatic pressure-driven fluid 
transport to simulate the environment cells encounter in- 
vivo. Whilst the choice of silicon-glass-silicon technology 
is an evolution of earlier designs it is still the only 
nonresearch technology offering the ability to implement 
two-level fluidics, sub-micron precision and anisotropic 
structuring techniques. 
Our measurements concern a delicate suspended phase 
of blood cells that reauire care with fluid flow conditions in 
Fig. I .  The instrument, detailing the macrofluidic circuit and the 
hydrostatic head mechanism to the left. The microfluidic device is 
positioned on the microscope stage. 
four-sided atray of approximately 1500, 100 pm long, circa 
3.5 pm section (depending upon channel design and device 
variant) plasma etched, flow channels. The array, detailed 
in Fig. 3, is fed by a central reservoir area of circa 17 pm 
depth formed by anisotropic wet etching. 
In the centre of the reservoir is a feed-via to the opposite 
wafer face, in fact this intercepts a similar via emerging 
from that face in order to minimise cross-sectional area and 
hence maximise suspension flow velocity and minimise cell 
sedimentation. 
order to avoid cell iysis and to avoid biasing of sample 
in single phase 
liquid systems. 
These restrictions are less Fig. 2. SEM of a flow device prior to anodic bonding ofthe glass cover. The device inlet port is in the centre of the picture. The WO 
outlet ports are at the top and bottom of the picture. 
B. Microfluidic Device Fabrication and Design 
The particular devices reported here, fabricated at the 
ZfM, Technische Universitat Chemnitz, employ double- 
sided silicon wafer processing with both faces of the wafer 
being sealed by anodic-bonded glass: the upper surface 
providing a viewing window, the lower having 
ultrasonically-drilled feed vias formed in the glass prior to 
bonding, thereby providing fluid connectivity. Device 
design considerations are further detailed in 1141 and [15]. 
Fig. 2 shows the upper face of the silicon featured with a 
Fig. 3.  SEM of an array of silicon microengineered flow channels. 
The wet-etch forming the vias operates on both wafer 
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faces concurrently and also, via crystal-plane self-limiting, 
forms flow-bypass manifolding on the lower face (this is a 
critical aspect of the micro-macro interfacing and is 
discussed below) as well as a waste collection 'gutter' 
outside the square array on the upper face. The completed 
silicon wafers are thermally oxidised to present a well 
defined hydrophilic surface and then anodic bonded and 
diced. 
Fig. 4 shows the resulting device mounted on a small 
printed circuit board (PCB) containing a closed-loop 
temperature control system to hold the chip at 37C (or any 
other desired temperature). Device heating is via a gold- 
plated copper mounting pad with chip resistors serving as 
heating elements. Fluid connectivity is provided by seven 
0.75 mm o.d., 0.25 mm i.d. nylon tubes fitted into 
ultrasonically drilled holes and sealed by epoxy adhesive. 
C. Macrofluid System Design 
Instrument miniaturisation was not our objective: rather 
we sought to benefit from the precision of the microfluidic 
flow device. Accordingly the extemal fluid system consists 
of miniature, but conventional, components. 
When dealing with suspended phases a problem 
associated with such a macro-micro interface is that the 
volume flow rates of the microfluidics, when translated into 
the tubing and components of the macro system is 
insufficient to counteract gravitational sedimentation of the 
suspended phase. In this system the microfluid chip results 
in typical flow rates of 2.5 picolitres per second. This not 
only has the potential to restrict the flow of cells to the 
microdevice, but more pemiciously it can dynamically 
change the local density of the fluid and hence the 
distribution of pumping losses (pressure drops) within the 
system extemal to the microfluidics resulting in an apparent 
intra-experimental pressure drift. 
The use of higher pressures to force higher flow rates is 
precluded by the lysis of any cells that are swept into, and 
consequently block, the channel array at elevated flow 
velocities. Such problems have determined a system design 
with direct injection of cell samples into a separate port in 
the lower face manifolding, hrthermore a branch of the 
manifolding provides for priming the blood sample through 
to waste without invoking the precision flow structures of 
the upper device plane. To a very large degree such a 
configuration isolates the priming of the main fluid circuits 
and microdevice from the blood circuitry. Indeed the blood 
Fig. 4. A PCB-mounted, seven port microfluidic device. 
circuit is primed and flushed by flow directed through the 
manifolding away from the device. 
Cells are measured at true physiological microvascular 
pressures in the (0-100) Pa range. The pressure is set by a 
highly precise hydrostatic head under computer control. 
Pressure zeroing is achieved by stopping a cell mid channel 
and calibrating the system at this point. 
D. Real-Time Image Processing and Data Post- 
processing 
Given the objective of measuring several thousand 
erythrocytes on a cell-by-cell basis it was never feasible to 
employ direct observation (although a few special purpose 
devices were employed in this manner). Accordingly, from 
the outset, the system has employed real-time, (data 
extraction at true video rates without frame buffering) grey- 
scale, image processing methods to concurrently extract 
channel transit velocity and a volume metric for each 
erythrocyte in a sample of approximately 1500. 
The image processing system including the manner in 
which the custom-written software automatically filters out 
ambiguous cell transits has largely remained unchanged 
since this instrument was reported in [6] .  
One of two forms of volume metric can be obtained 
during analysis: a measurement of the cell length within the 
channel or a relative measurement of the cell volume, based 
on the relative absorbency by the cell of 400 nm incident 
illumination. This wavelength corresponds to an absorbency 
peak of haemoglobin within the cells and hence results in 
video images of dark cells against a reflective silicon 
background. A typical video image is shown in Fig. 9. 
The cell volume measurements are described as metrics 
to recognise that they are relative measurements. This is 
particularly the case for measurement of cell len@ where a 
monotonic relationship between cell length and actual 
volume is assumed. However, the instrument's volume 
measurements have been shown to agree excellently with 
absolute volume measurements obtained using the 
Technicon H2 Haemocytometer: a standard haematological 
instrument [ 161. 
Subsequent to the image processing stage the resultant 
data is analysed in simpler cases by packages such as 
Microsoft Excel. However for more detailed analyses we 
employ the technique of Kemel Density Estimation (KDE) 
[17]. This technique provides insight into the spatial density 
of cells within volume-velocity space. 
111. METHODS 
A.  Fluidic Operating Procedure 
Bubbles are a notorious practical problem in microfluid 
systems. In our system they can manifest themselves in two 
ways: if they lodge in narrow cross-section areas of the 
microfluidics they can totally interrupt fluidic operation by 
virtue of the high net meniscus forces they possess. 
Conversely, in larger bore, millifluid, areas they may not 
occlude the channel, but rather gently float upwards causing 
an associated pumping effect. In this system errors of a few 
Pascals are sufficient to invalidate experiments and we have 
observed such errors being induced by flowing bubbles. 
In order to ensure a bubble-free fluid system, the 
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complete fluid circuit is first primed with high purity carbon 
dioxide 1181 and then with 1.2 pm filtered, degassed 
phosphate buffered saline (PBS). The microfluidic device is 
then primed with the erythrocyte suspension by application 
of a pneumatic over-pressure. Having primed the cells to 
the lower face of the device, cell flow through the channels 
is controlled by application of a hydrostatic pressure 
differential across the device. 
When multiple samples are tested within a single 
experiment, the fluid system is flushed with PBS between 
samples. 
B. Blood Preparation 
I )  Normal blood : 3 ml of blood was obtained from a 
healthy adult via venepuncture. Following centrifugation for 
five minutes at 3000 g the plasma was aspirated from the 
sample and the white bloods cells and platelets were 
carefully removed and discarded. The erythrocytes were re- 
suspended in PBS then washed three times. Finally, the 
erythrocytes were suspended, at a haematocrit (cell 
concentration by volume) of 3 YO, in PBS containing 5 % 
autologous plasma. Prior to use, all suspending media were 
filtered to 1.2 pm. All samples of normal blood presented in 
this paper were prepared in this manner. 
2) Artffcially treated cells : Erythrocytes from a 3 ml 
normal sample were isolated and washed as described 
above. The cells were then re-suspended at a 10 % 
haematocrit in PBS containing 0.3 mg/ml phenylhydrazine 
hydrochloride (Sigma Chemicals) and incubated for 1 hour 
at 37C. The erythrocytes were then washed once more and 
re-suspended in 5 YD autologous plasma as above. 
3) Thalassaemic cells ; 10 ml blood samples were 
withdrawn, immediately prior to transfusion, from a 
splenectomised, P-thalassaemia-major patient attending the 
Haematology Clinic of the Royal Free Hospital, London. 
The sample was prepared as per normal blood. 
IV. RESULTS AND DISCUSSION 
A. Normal Blood 
It was discussed earlier that the ultimate data output of 
the instrument is a concurrent measurement of the velocity 
and length, or volume index, of each erythrocyte in a large 
sample as it transits a microchannel within the microfluidic 
device. The plot shown in Fig. 5 is a typical example of a 
sample of healthy adult erythrocytes. This data was 
obtained for cells passing through channels of 3.0 pm width 
x 3.2 pm depth x 100 pm length, under a driving pressure 
The most distinctive feature of the results shown in Fig. 
5 is the highly significant (P < 0.0005, r = -0.82) inverse 
linear relationship between erythrocyte length and velocity. 
It should be emphasised here that each point on the 
scatterplot represents a paired measurement of a single cell. 
In this case the sample size was 1491. 
Of 5 mm of HzO. 
0 2 4 6 8 I D  12 14 
Cell length (vm) 
Fig. 5 .  Erythrocyte length/velocity scatterplot of a normal sample. 
By way of illustrating the inter-experimental 
reproducibility of the instrument, largely in terms of the 
repeatability of pressure setting accuracy, multiple 
measurements were made on a single sample under 
identical operating conditions. Fig. 6 shows the linear fits of 
the three worst matched (for the sake of clarity) of nine 
experimental runs performed using the same channel array. 
Whilst a thorough statistical analysis of the results is not 
presented here, Fig. 6 serves to indicate the high level of 
experimental repeatability. Clearly this is an essential 
prerequisite to the serious analysis of biophysical or clinical 
samples. 
Reference [9] reports manual, paired cell size and 
velocity measurements of erythrocytes passing through 
repeated banks of 12 pm long microchannels. Resting 
erythrocyte diameter was taken as a measure of cell size. 
Ensuing measurements of 23 cells yielded no significant 
correlation between cell size and velocity: a result in sharp 
contrast to those presented here. In the absence of any 
reported detail of the supporting fluid system, or indication 
of the fidelity of pressure control achieved, a loss of 
isobaric conditions during the course of measurements may 
well explain their lack of correlation. 
B. Chemically Treated Blood 
ldentification of sub-populations of rigid cells is deemed 
important when evaluating pathologically altered blood 
[19]. To illustrate the resolution afforded by a paired, bi- 
50 I 
Cell lensh ( I I ~ )  
Fig. 6 .  Comparison of thc linear regrcssion lines for data obtained 
from three identical experimental runs. 
variate measurement process, an erythrocyte suspension 
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containing a 10 % sub-population of artificially treated cells 
within a normal sample was analysed. The sub-population 
was treated with phenylhydrazine hydrochloride to reduce 
the intrinsic mechanical deformability of the cell 
membranes. Fig. 7a presents the results of such a sample, 
measured in a channel array containing channels measuring 
3.5 wide pm x 3.2 pm deep x 100 pm long. The driving 
pressure was 7 mm of HZO. For comparison, a pure sample 
of the normal cells was also measured under identical 
conditions and these results are shown in Fig. 7b. 
The existence of a sub-population of abnormally slow 
moving cells is clearly evident from Fig. 7a. If we consider 
only a uni-variate presentation of the data as shown in the 
figure inset which presents the velocity distribution of the 
sample, then the sub-population i s  not apparent. Whilst 
there appears to be a low velocity tail to the distribution, it 
is impossible to determine the mechanism responsible. An 
erythrocyte sample with an extended volume range may 
well produce such a velocity distribution. The concurrent 
measurement of velocity and a volume index allows the 
sub-population to be clearly differentiated from the normal 
population. Revealingly, it can be seen that the slow 
moving cells are of normal size, thus clearly indicating 
some impairment of the intrinsic material mechanical 
properties of these cells. 
350 
j I ~ I  
......... , ........ i ........ 2 .  ... . .  . I .  ... ..., .......... 
350 
I 
~ (bl ........... 1 ......... 1 .......... L ......... :...~ . . . . . . . . . . .  . . . . . . . . . . . . . .  
! 
0 2 4 6 8 10 12 14 
I (bl 
300 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I . . . .  1 .  ...... ".! ........... ' ........... 
350 
Cell length (pm) 
Fig. 7. a) Erythrocyte lengthivelocity scatterplot of a normal cell 
sample containing a 10 % (by volume) sub-population of 
chemically hardened cells. The inset shows the velocity 
distribution of the same data. b) Erythrocyte length/velocity 
scatterplot of a pure sample of the normal cells. 
0 2 4 6 8 10 12 14 16 
Cell length (pm) 
Fig. 8. a) Etythrocyte lengthlvelocity scatterplot of cells from a 
transfused, splenectomised thalassaemic patient. b) Erythrocyle 
length/velocity scatterplot of cells from a healthy control. Thc 
figure insets show KDE contour plots of the data. 
seen that these fast cells were very clearly haemoglobin- 
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poor or hypochromic. 
The thalassaemic patient had undergone a blood 
transfusion four weeks prior to blood sample collection: a 
fact which leads to a certain ambiguity in interpreting the 
results, as the sample inherently included two distinct cell 
populations. Looking at Fig. 8a and Fig. 8b in conjunction, 
one interpretation of the data is that the transfused cells are 
shown as the high datapoint density region appearing 
towards the large end of the cell range (approximately 9 pm 
and greater) on Fig. 8a. The microcytic and larger 
hypochromic cells are assumed to be thalassaemic. The 
contour plot representations of the data emphasise the 
relatively good mapping between the ‘transfused’ 
population of the thalassaemic sample and the normal 
sample in Fig. 8b. 
It is clear from Fig. 8 that the microchannel flow of 
these thalassaemic eryfhrocytes is not detrimentally affected 
when compared with normal cells. Although intrinsic 
mechanical properties of thalassaemic cells have been 
shown to be impaired [20], here we suggest that due to their 
microcytosis and hypochromia, thalassaemic erythrocytes 
may actually exhibit beneficial flow properties in a 
microvessel environment. 
V. CONCLUSIONS AND FURTHER WORK 
The employment of precise microfluidic components 
allied with a very carefully optimised fluid control and data 
extraction system has allowed us to investigate the 
microflow properties of normal, chemically altered and 
pathological erythrocytes to a precision hitherto impossible. 
In particular we have measured samples of circa 1500 cells 
characterising each cell in terms of a volume index and flow 
velocity. By this means we can independently examine the 
flow of a cell in terms of its intrinsic cell-membrane 
mechanical properties and its extrinsic property of volume. 
We are currently experimenting with more advanced 
flow channels of varying section as shown in Fig. 9 which 
sequentially subject the cell to static, and then dynamic, 
deformation. This offers the prospect of separating effects 
due to changes in the elastic modulus of the cell membrane, 
goveming static deformation, from their viscous 
component, governing the dynamic behaviour. 
Fig 9. Image of erythrocytes flowing through channels containing 
parallel-walled and varying cross-section elements for observing 
static and dynamic cellular deformation .Flow is from left to right 
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